HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers
about
Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophreniaA natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxisAssociation of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cellsCripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cellsActivation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferationPhosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell linesAnalysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factorA comprehensive pathway map of epidermal growth factor receptor signalingRAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasionBinding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesisExpression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour typesErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migrationThe relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cellsThe ErbB signaling network: receptor heterodimerization in development and cancerThe type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases.ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutationExtracellular domains drive homo- but not hetero-dimerization of erbB receptorsFulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1Trans-regulation of Syndecan Functions by Hetero-oligomerizationErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.Functional selectivity of EGF family peptide growth factors: implications for cancer.Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.Targeting erbB receptors.Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.Gene expression profiling of ErbB receptor and ligand-dependent transcription.EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3.Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor.Specificity within the EGF family/ErbB receptor family signaling network.A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.Signaling by ERBB4
P2860
Q21203806-F7CE40FC-2015-4695-A3FD-BB728D5417C2Q22253346-37D2F98A-4ABD-49DC-9111-876D9B06A5C3Q24314260-29D95471-B9D8-4263-A8EB-CF787EF398F2Q24316433-7465524B-BF1F-4615-82A7-0D3F0F35F800Q24318527-1F1A2347-9939-45DB-958C-F1EFEF4BE406Q24318725-FD35D61A-9623-43F4-BFDF-2DA2CA4ABE51Q24319261-17996D33-8B80-4442-868D-D2765075BB3AQ24522643-382F8E70-26E0-4583-8FC2-46C103FFAFE5Q24537669-E13AD298-138A-4AF6-BBBF-805DACB66A1EQ24648517-A6B423FF-825E-4AF1-A572-A0D4B4978B9CQ24672490-353AEB09-39EF-4D44-961E-069D8A5F61D1Q28138365-E911E8B5-8CF0-49F2-86B8-DB02C8EE9D04Q28269163-82160BA4-BFD4-42EF-A6D5-F5C2ED15C180Q28285266-54AC248A-D5BC-4516-A3CD-5D314B9DAD51Q28578116-D12458EA-BC55-467D-A4F5-E49A70F321F5Q28678816-C125F10D-25B6-4141-BD0A-D12C0E19CEF6Q29617919-1A403DA3-687A-4F64-BF94-BF5DFB6B8E3EQ33538424-71C9F80B-6627-42A1-B3D7-0A9CCB74D27DQ33700160-949BD74E-87D1-4553-AB05-097887561F67Q33886341-B275022B-9494-49D4-9E4D-82371CF6222BQ33902463-14513DEA-2062-475C-9D08-323E03A07CEFQ34488149-64F0CCC1-ECAB-4EBF-8203-ADFEAEA1C7E5Q35558954-B257FF6B-C236-444E-BB41-3AEAB8001A51Q35860571-12606928-55FD-49AA-8699-7D9099A72EEBQ35885511-46D72DF4-2377-4B4E-8CEC-77E5B788EFA3Q36490427-4310A9BA-70D8-45A0-9B2E-288DAD93FD1EQ37021760-03D9B08B-8210-48EB-9B59-54E9DAE2B9BBQ37149729-B3D778EF-83B9-4C5A-AF82-713EBA5199FEQ37420570-1349F5D5-EBEF-4062-99C2-BDE1D04EB543Q37650953-6C9CA646-6057-4791-86C5-BD95C5CF0047Q37789955-794055ED-EA6D-4CC2-A482-24F6D49569D3Q38300650-47768865-D81C-4067-A6CC-6969059A9B82Q40587910-2FDA9F22-55F9-4783-8AB7-20F9E750D95BQ40678332-ACCB6DBD-A49E-4F44-82F6-B646F4959A78Q41072421-929D0374-6DE2-4726-900C-2685E5062861Q41705572-A32F688D-D5C5-4D21-8EAA-FD048E1E3B80Q41721612-4CCF627B-58C9-49C9-90CB-AC4FAAAA0E83Q42157204-DB7F66E1-CF56-4F47-8BD5-3CC0937D64AFQ42493129-8D5DC83C-FA10-45BD-8551-E1D47823A48DQ45318103-017B8C42-A032-44C1-8898-83FCFB74F1D5
P2860
HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@ast
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en-gb
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@nl
type
label
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@ast
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en-gb
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@nl
prefLabel
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@ast
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en-gb
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@nl
P2093
P921
P356
P1476
HER4-mediated biological and b ...... nce for HER1-HER4 heterodimers
@en
P2093
P304
P356
10.1074/JBC.271.9.4813
P407
P577
1996-03-01T00:00:00Z